Written by cpm
It’s no secret the industry is still learning about how to get the best out of biostimulants. CPM interrogates the latest data from trials carried out by NIAB to find out more about the responsiveness of different wheat varieties to Bridgeway application. Amino acid pathways are critical to the plant’s immune system. By Lucy de la Pasture The subject of biostimulants is one that divides opinion. Inconsistent and unpredictable results in independent trials, particularly in wheat, have raised question marks as to whether they really have a role to play or not. The data from Interagro’s own trials over the past three seasons (2017-2019) in cereals has thrown up wildly different yield responses, ranging from -0.3t/ha to +3.0t/ha, with the best results achieved in the stressful growing periods of 2017 and 2018, says Stuart Sutherland, technical manager at Interagro. The question is why? In an effort to better understand what may be happening, Interagro enlisted the help of NIAB in 2020 to delve deeper and look at winter wheat variety responses to the application of its amino acid biostimulant, Bridgeway. “Apart from defence pathways regulated by the typical stress hormones, certain amino acid pathways are also critical to the…
The post Pushing performance – Varietal differences revealed appeared first on cpm magazine.
Continue reading on CPM website...
If you are enjoying what you read then why not considering subscribing:
